Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» Business development
Business development
Latest News
EOFY Share Valuation Information
August 10, 2026
EOFY Share Valuation Information
Read More
Half Yearly Financial Report
July 6, 2026
26-07-01 BioDiem Limited Half-year Financial Report 31Dec2025
Read More
